Belimumab Assessment of Safety in SLE

Clinical trial NCT01705977 · COMPLETED

Trial details

NCT number: NCT01705977
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2012-11-27
Primary completion: 2018-07-30
Enrollment: 4019

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.